Forte Biosciences, Inc. Common Stock

FBRXNASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
21.03 USD
↗ 2.32 (12.40%)AT CLOSE (11:59 AM EDT)
20.88
↘ 0.15 (0.71%)
POST MARKET (AS OF 04:44 PM EDT)
Post Market
AS OF 04:44 PM EDT
20.88
↘ 0.15 (0.71%)
🔴Market: CLOSED

Forte Biosciences, Inc. Common Stock (FBRX) trades at $21.03 per share. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". This is driven by a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation front, FBRX trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Jun 26, 2026.

Open?$18.77
High?$21.53
Low?$18.41
Prev. Close?$18.71
Volume?3.1M
Avg. Volume?339.4K
VWAP?$20.36
Rel. Volume?9.07x
Bid / Ask
Bid?$13.24 × 100
Ask?$31.64 × 100
Spread?$18.40
Midpoint?$22.44
Valuation & Ratios
Market Cap?430.7M
Shares Out?20.5M
Float?7.5M
Float %?60.0%
P/E Ratio?N/A
P/B Ratio?10.23
EPS?-$3.70
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
Themes
Biotech - Drug Development›Immunology & AutoimmuneBiotech - Drug Development›Rare Disease Therapeutics
Employees
22
Market Cap
383.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.fortebiorx.com
Listed
2020-06-16
Address
3060 PEGASUS PARK DRIVE
DALLAS, TX 75247
Phone: (310) 618-6994
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
40
Momentum?
50
Short Sent.?
46
Piotroski F-Score?0/9Weak
Altman Z-Score?2.13Grey
Confidence?57%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?19.45%High
Short Interest?1.5M
Days to Cover?5.1
Free Float7.5M
Avg Daily Volume287.6K
Settlement Date2026-06-15
Financial Health
Current Ratio?2.75Strong
Quick Ratio?2.75Strong
Cash Ratio?2.46Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
19
10.23HIGH▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.8CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-180.2%WEAK▾
ROA?
S&P
3
-112.8%WEAK▾
Cash Flow & Enterprise
FCF?$-59390000
Enterprise Value?$372.4M
Fundamentals ratios updated end of day
MarketsMoversWatchlist